Review Article
Pentraxin 3: A Novel Biomarker for Inflammatory Cardiovascular Disease
Table 1
Geometric mean PTX3 plasma levels by CHD risk factors [
17].
| Risk factor | PTX3 (ng/mL; 95% CI) | value |
| TCHO | ≧220 mg/dL | 2.16 (1.85–2.46) | 0.51 | <220 mg/dL | 2.30 (2.01–2.60) | HDL | ≧40 mg/dL | 2.23 (1.98–2.48) | 0.42 | <40 mg/dL | 2.03 (1.62–2.43) | HgbA1C | ≧5.9% | 2.12 (1.83–2.42) | 0.29 | <5.9% | 2.36 (2.02–2.66) | Obesity | ≧24.2 kg/m2 | 1.98 (1.64–2.32) | 0.07 | <24.2 kg/m2 | 2.39 (2.12–2.67) | IMT | ≧1.0 mm | 2.30 (2.02–2.58) | 0.56 | <1.0 mm | 2.24 (1.80–2.68) | Smoke | Smoking | 2.32 (1.96–2.68) | 0.58 | None | 2.20 (1.93–2.47) | Gender | Male | 2.26 (1.97–2.54) | 0.84 | Female | 2.22 (1.93–2.51) |
|
|
CHD: coronary heart disease. TCHO: total cholesterol; HDL: high-density lipoprotein; HgbA1C: hemoglobin A1C; IMT: intimal media thickness. CI: confidence interval.
|